What are the characteristic tissue Doppler values in restrictive cardiomyopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tissue Doppler Values in Restrictive Cardiomyopathy

In advanced restrictive cardiomyopathy, tissue Doppler demonstrates severely reduced mitral annular e′ velocities of 3-4 cm/s at both septal and lateral sites, with a characteristic pattern showing higher lateral e′ compared to septal e′ (unlike constrictive pericarditis), combined with an E/e′ ratio >14. 1

Key Tissue Doppler Characteristics

Early Diastolic Velocity (e′)

  • Septal e′: 3-4 cm/s in advanced disease 1
  • Lateral e′: 3-4 cm/s in advanced disease 1
  • Critical diagnostic pattern: Lateral e′ > septal e′ (termed "annulus reversus") distinguishes RCM from constrictive pericarditis where septal e′ is typically higher 1
  • Cutoff value <8 cm/s at both septal and lateral annulus has 95% sensitivity and 96% specificity for restrictive cardiomyopathy versus constrictive pericarditis 2

Systolic Velocity (S′)

  • Markedly reduced S′ velocities: Septal S′ approximately 4.1 ± 1.5 cm/s and lateral S′ approximately 4.3 ± 1.9 cm/s 3
  • Combined cutoff <8 cm/s for both S′ and e′ at lateral and septal annulus demonstrates 93% sensitivity and 88% specificity for RCM diagnosis 3

E/e′ Ratio

  • E/e′ ratio >14 indicates markedly elevated left atrial pressure 1
  • This ratio is significantly elevated in RCM (approximately 25.1 ± 8.7) compared to constrictive pericarditis (11.2 ± 8.8) 4

Disease Stage Variations

Early Stage RCM

  • Diastolic function may show Grade 1 dysfunction (impaired relaxation with normal LV filling pressures) 1
  • Can progress to Grade 2 dysfunction (pseudonormalization pattern) 1

Advanced Stage RCM (Grade 3 Diastolic Dysfunction)

  • Restrictive filling pattern with mitral E/A ratio >2.5 1
  • Deceleration time (DT) <150 msec (often <140 msec for high specificity) 1
  • Isovolumic relaxation time (IVRT) <50 msec (high specificity) 1
  • Severely reduced e′ velocities as described above 1
  • LA volume index >50 mL/m² (markedly increased) 1

Critical Diagnostic Pitfalls

The presence of normal or near-normal annular e′ velocity (≥8 cm/s) in a patient with suspected heart failure should raise strong suspicion for constrictive pericarditis rather than restrictive cardiomyopathy. 1 This is the single most important distinguishing feature.

Subtype Differences

In cardiac amyloidosis specifically, e′ velocities are even lower (4.6 cm/s) compared to primary restrictive cardiomyopathy (6.3 cm/s), though both remain well below the 8 cm/s threshold 2. There is often no overlap in e′ values between constrictive pericarditis and cardiac amyloidosis 2.

Prognostic Significance

Grade 3 diastolic dysfunction with these severely reduced tissue Doppler values is associated with poor outcomes in restrictive cardiomyopathy patients. 1 The combination of restrictive physiology on conventional Doppler with profoundly reduced tissue velocities indicates advanced myocardial disease with markedly elevated filling pressures 1.

Measurement Technique Considerations

  • Measurements should be obtained at both septal and lateral mitral annulus using pulsed-wave tissue Doppler 1, 3, 4
  • Sweep speed of 100 mm/sec is recommended for accurate measurements 1
  • The e′ velocity must be distinguished from biphasic velocity during isovolumic relaxation period 1
  • Gain and filter settings should be optimized to avoid high gain that can distort measurements 1

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.